We studied the effect of cytostatic rapamycin on the antitumor activity of 5-fluorouracil (5-FU). To this end, HT-29 cells were treated with 5-FU, or rapamycin, or their combination. The proliferation and apoptosis of treated cells were evaluated using Cell Counting Kit-8 kit and flow cytometry, respectively. The autophagy was evaluated by transmission electron microscopy and Western blotting by the expression of p62, LC3I, and LC3II proteins. 5-FU inhibited proliferation and promoted apoptosis of HT-29 cells, and the combination of 5-FU with rapamycin potentiated both effects. Rapamycin promoted accumulation of autophagosome/autolysosome and enhanced the level of LC3II/LC3I. Thus, rapamycin enhances the antitumor activity of 5-FU by stimulating autophagy and increasing LC3II/LC3I. The results confirm a potential therapeutic strategy for the clinical application of 5-FU.
Similar content being viewed by others
References
Blagosklonny MV. Rapamycin for longevity: opinion article. Aging (Albany NY). 2019;11(19):8048-8067. https://doi.org/10.18632/aging.102355
Chen J, Lu H, Yan D, Cui F, Wang X, Yu F, Xue Y, Feng X, Wang J, Wang X, Jiang T, Zhang M, Zhao S, Yu Y, Tang H, Peng Z. PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy. Oncotarget. 2015;6(1):355-67. https://doi.org/10.18632/oncotarget.2803
Delgoffe GM, Pollizzi KN, Waickman AT, Heikamp E, Meyers DJ, Horton MR, Xiao B, Worley PF, Powell JD. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 2011;12(4):295-303. https://doi.org/10.1038/ni.2005
He XX, Huang CK, Xie BS. Autophagy inhibition enhanced 5-FU-induced cell death in human gastric carcinoma BGC-823 cells. Mol. Med. Rep. 2018;17(5):6768-6776. https://doi.org/10.3892/mmr.2018.8661
Liu C, Liu L, Zhu HD, Sheng JQ, Wu XL, He XX, Tian DA, Liao JZ, Li PY. Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux. Sci. Rep. 2018;8(1):4108. https://doi.org/10.1038/s41598-018-22339-0
Sato M, Seki T, Konno A, Hirai H, Kurauchi Y, Hisatsune A, Katsuki H. Rapamycin activates mammalian microautophagy. J. Pharmacol. Sci. 2019;140(2):201-204. https://doi.org/10.1016/j.jphs.2019.05.007
Svatek RS, Ji N, de Leon E, Mukherjee NZ, Kabra A, Hurez V, Nicolas M, Michalek JE, Javors M, Wheeler K, Sharp ZD, Livi CB, Shu ZJ, Henkes D, Curiel TJ. Rapamycin Prevents Surgery-Induced Immune Dysfunction in Patients with Bladder Cancer. Cancer Immunol. Res. 2019;7(3):466-475. https://doi.org/10.1158/2326-6066.CIR-18-0336
Tanida I, Ueno T, Kominami E. LC3 and Autophagy. Methods Mol. Biol. 2008;445:77-88. https://doi.org/10.1007/978-1-59745-157-4_4
Wang M, Han D, Yuan Z, Hu H, Zhao Z, Yang R, Jin Y, Zou C, Chen Y, Wang G, Gao X, Wang X. Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy. Cell Death Dis. 2018;9(12):1149. https://doi.org/10.1038/s41419-018-1187-4
Wang Y, Zhang H. Regulation of Autophagy by mTOR Signaling Pathway. Adv. Exp. Med. Biol. 2019;1206:67-83. https://doi.org/10.1007/978-981-15-0602-4_
Wei Y, Yang P, Cao S, Zhao L. The combination of curcumin and 5-fluorouracil in cancer therapy. Arch. Pharm. Res. 2018;41(1):1-13. https://doi.org/10.1007/s12272-017-0979-x
White E, Mehnert JM, Chan CS. Autophagy, Metabolism, and Cancer. Clin. Cancer Res. 2015;21(22):5037-5046. https://doi.org/10.1158/1078-0432.CCR-15-0490.
Xu M, Bu LM, Wu K, Lu LG, Wang XP. Rapamycin inhibits the proliferation of SW1990 pancreatic cancer cell. Eur. Rev. Med. Pharmacol. Sci. 2015;19(16):3072-3079.
Yang D, Qu J, Qu X, Cao Y, Xu L, Hou K, Feng W, Liu Y. Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells // Cancer Chemother. Pharmacol. 2015;76(3):575-586. https://doi.org/10.1007/s00280-015-2749-0
Zhang S, Zheng F, Zhang L, Huang Z, Huang X, Pan Z, Chen S, Xu C, Jiang Y, Gu S, Zhao C, Zhang Q, Shi G. LncRNA HOTAIR-mediated MTHFR methylation inhibits 5-fluorouracil sensitivity in esophageal cancer cells. J. Exp. Clin. Cancer Res. 2020;39(1):131. https://doi.org/10.1186/s13046-020-01610-1
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 173, No. 4, pp. 456-461, April, 2022
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chen, S., Yang, J., Wang, F. et al. Rapamycin Enhanced Sensitivity of HT-29 Cells to 5-Fluororacil by Promoting Autophagy. Bull Exp Biol Med 173, 448–453 (2022). https://doi.org/10.1007/s10517-022-05585-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-022-05585-1